Management of chronic kidney disease

Medicine

Volumn 35, Issue 8, 2007, Pages 442-446

  Tomson, C ^a,b   Udayaraj, U ^a,b  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

antihypertensive therapy; chronic disease management; chronic kidney disease; glomerulonephritis; progression

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIRFENIDONE; RAPAMYCIN; RHO KINASE INHIBITOR; SCATTER FACTOR; THIAZIDE DIURETIC AGENT; VERAPAMIL;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DOSE KIDNEY FUNCTION RELATION; DRUG CLEARANCE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; HYPERKALEMIA; HYPOTENSION; HYPOVOLEMIA; KIDNEY CLEARANCE; KIDNEY DYSFUNCTION; LACTIC ACIDOSIS; MONOTHERAPY; OBESITY; PATIENT IDENTIFICATION; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RENAL REPLACEMENT THERAPY; REVIEW; RISK MANAGEMENT; SMOKING CESSATION; SODIUM RESTRICTION;

EID: 34447636546     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2007.05.010     Document Type: Review

References (15)

1. Bodenheimer T., Wagner E.H., and Grumbach K. Improving primary care for patients with chronic illness. JAMA 288 (2002) 1775-1779
2. Bodenheimer T., Wagner E.H., and Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 288 (2002) 1909-1914
3. Joint Specialty Committee for Renal disease of the Royal College of Physicians of London and the Renal Association. Chronic kidney disease in adults: UK guidelines for identification, management, and referral (2006), Royal College of Physicians of London, London
4. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
5. The Royal College of Physicians of Edinburgh TSRA, and the Renal Association. UK consensus statement on chronic kidney disease (2007). http://www.rcpe.ac.uk/Whats_New/consensus-statements/final-early-chronic -kidney-disease.doc
6. Garg A.X., Kiberd B.A., Clark W.F., Haynes R.B., and Clase C.M. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 61 (2002) 2165-2175
7. Lindeman R.D., Tobin J.D., and Shock N.W. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26 (1984) 861-868
8. Fliser D., Franek E., and Ritz E. Renal function in the elderly-is the dogma of an inexorable decline of renal function correct?. Nephrol Dial Transplant 12 (1997) 1553-1555
9. Heeg J.E., de Jong P.E., van der Hem G.K., and de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36 (1989) 272-279
10. Williams B., Poulter N.R., Brown M.J., et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 18 (2004) 139-185
11. Jafar T.H., Stark P.C., Schmid C.H., et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 139 (2003) 244-252
12. National Institute for Clinical Excellence. Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. 1st edn (2004), Royal College of Physicians, London
13. Nakao N., Yoshimura A., Morita H., Takada M., Kayano T., and Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361 (2003) 117-124
14. Ruggenenti P., Perna A., Benini R., and Remuzzi G. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). J Am Soc Nephrol 9 (1998) 2096-2101
15. Sprangers B., Evenepoel P., and Vanrenterghem Y. Late referral of patients with chronic kidney disease: no time to waste. Mayo Clin Proc 81 (2006) 1487-1494